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AMONGST the more important results of chromosome studies in human leukae-
mias is the occasional demonstration of increasing genetic variation as evidenced
by the appearance of a range of cell lines of differing chromosomal constitution.
The finding of a variety of cell lines which are not obviously related is common in
cases of acute leukaemia and in chronic granulocytic leukaemia at the stage of
acute transformation. Only rarely has it been possible by serial study to trace the
development of increasing genetic variation and still more rarely to propose any
scheme for the interrelationship ofthe various cell lines. Outstanding exceptions
include a case of acute leukaemia studied by Ford and Clarke (1963), a case of
chronic granulocytic leukaemia in acute transformation reported by Court Brown
and Tough (1963), and a series of cases with chronic granulocytic leukaemia
described by de Grouchy and his colleagues (1966).
The importance of cases in which the cell lineage can be deduced is that these
successive alterations ofkaryotype may indicate cytogenetic steps essential to the
development ofincreasing malignancy and cellular autonomy. Ifa pattern can be
discerned in these successive changes, it will have implications important for the
study of neoplastic disease in general. We have recently studied two cases of
chronic granulocytic leukaemia at the stage ofacute transformation in which some
possible relationships between a range of cell lines may be deduced.
CASE REPORTS
Case 1
A man, aged 46, presented with clinical and haematological features typical of
chronic granulocytic leukaemia. Initial treatment by splenic irradiation was
followed by a satisfactory remission which was, however, short-lived. The
response to treatment with busulphan was unsatisfactory. Further splenic
irradiation led to an incomplete and transient remission, and a second course of
busulphan waswithout beneficial effect. Atthattime hehadsevere constitutional
symptoms with rapidly progressive splenomegaly and increasing numbers of blast
cells and basophils in the peripheral blood. Acute transformation of chronic
granulocytic leukaemia was diagnosed 8 months after his initial presentation in the
chronic phase ofthe disease. Treatment with 6-mercaptopurine was followed by a
rapid fall in white cell count accompanied by some clinical improvement without
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reduction in splenomegaly. After 5 weeks of 6-mercaptopurine the white cell
count was 8000/c.mm. with 49% neutrophils, 5% stab forms, 2% metamyelocytes,
5% myelocytes, 7% myeloblasts, 20% lymphocytes, 3% monocytes and 9%
basophils. At that time aspiration biopsy ofthe bone marrow was carried out for
morphological and cytogenetic studies. Romanowsky-stained marrow smears
showed myeloid hyperplasia with a preponderance ofblast cells.
Soon after this examination the patient's general state deteriorated and the
white cell count rose once more, despite an increased dose of 6-mercaptopurine.
Initial sensitivity to this drug had been only partial, as evidenced by the persisting
splenomegaly, and complete resistance had now arisen. Prednisolone in a dose of
60 mg. daily was without effect. Treatment with demecolcine led to leucopenia
and hyperuricaemia with temporary oliguria. On cessation ofthe drug the white
cell count rose to 330,000/c.mm., of which 92% were blast cells. Demecolcine
was restarted in a low dose and the white cell count had begun to fall when the
patient died suddenly of haemorrhage from a ruptured splenic infarct. Death
occurred 11 months after the initial diagnosis of chronic granulocytic leukaemia
and 12 weeks after acute transformation had become obvious. Necropsy showed
splenomegaly with infarction and haemorrhage, leukaemic infiltration of spleen
and bone marrow, pulmonary oedema and bilateral pyelonephritis.
Materials and methods
Chromosome preparations were made from bone marrow aspirate by a modifica-
tion of the technique of Tjio and Whang (1962), with exposure of the cells to
demecolcine in vitro without prior culture. Chromosomes were stained with aceto-
orcein.
Results
In the direct preparation of bone marrow there were only 25 metaphases in
which the chromosome number could be unequivocally determined. The chromo-
some count distribution is shown in Table I. Karyotypic analysis was possible
TABLE I.-Case 1-Chromosome Count Distribution in Direct Preparation of Bone
Marrow
Chromosome No. . <45 . 45 . 46 . 47 . 48. 49 . 50 . 51 . >51
No. cells . . 0. 2. 1. 8 .10. 1. 0. 3. 0 Total 25
in all 25 metaphases, and a variety of cell types, all possessing 1 or 2 Philadelphia
chromosomes (Ph') was demonstrated (Fig. 1). In Table II, the cells are grouped
by karyotype into 11 categories. The numbers of cells in some ofthese categories
are small but others appear to constitute definite cell lines.
Case 2
A man, aged 57, had had chronic granulocytic leukaemia for 3- years. He had
been treated with splenic irradiation, busulphan, 6-mercaptopurine and predniso-
lone. Six months preceding study he developed localized tumours in the left
breast, vertebral bodies and spinal canal, with resultant paraplegia. Although at
this time examination of the peripheral blood and of bone marrow aspirate
suggested that his disease remained in the chronic phase, it was thought that these
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TABLE II.-Case 1-Chromosomal Constitution of Cell Lines Present
in Bone Marrow
No. of small
acrocentrics,
Cell No. cells Chromosome including No. of Phl
line present No. Phl and Y. chromosomes Comment
a . 2 . 45 5 . 1 . One 6-12
missing
b 1 46 . 5 . 1
c . 4 . 47 . 5 . 1 . Extra 6-12
cl . 1 . 47 . 5 . 1 . Extra No. 1
d . 2 . 47 . 6 . 2
e . 1 . 47 . 5 . 2 . Extra6-12
f . 2 . 48 . 5 . 2 . 2 extra6-12
g . 7 . 48 . 6 . 2 . Extra6-12
h . 1 . 48 . 7 . 2
i . 1 . 49 . 7 . 2 . Extra 17-18
3 . 51 . 7 . 2 . 2 extra6-12
Extra 17-18
Total . 25
extramyeloid tumours probably represented new neoplastic cell lines and that
metamorphosis had occurred. At the time ofhis death 6 months later, the white
cell count was 17,000/c.mm. with 33% neutrophils, 11% stab forms, 1% meta-
myelocytes, 5% promyelocytes, 20% lymphocytes and 30% myeloblasts despite
treatment with 6-mercaptopurine. He died with septicaemia and recurrent
gastrointestinal haemorrhage. Necropsy showed leukaemic infiltration of liver,
spleen, kidneys and bone marrow. Histological sections of the spleen showed
gross infiltration with primitive cells of the myeloid series with large bizarre
nuclei and an open chromatin pattern.
Materials and methods
Fifteen minutes after death, part of the grossly enlarged spleen was excised
with full aseptic precautions. By a method previously described (Spiers and
Baikie, 1965, 1966) a suspension ofspleen cells was prepared and cultured in vitro
for 19 hours in TC 199 containing 25% foetal calf serum. Phytohaemagglutinin
was not added to the culture. Metaphase figures were prepared from the cell
culture by a modification ofthe method ofMoorhead et al. (1960), and stainedwith
Giemsa. Longer-term cultures with added phytohaemagglutinin grew a para-
colon bacillus which may have been the cause ofthe patient's septicaemia.
Results
The chromosome count distribution of 97 well-spread metaphases from the
short-term culture is shown in Table III. The count distribution suggests the
EXPLANATION OF PLATE.
FIG. 1.-CASE 1-Metaphase of bone marrow cell spread by air-drying technique and stained
with aceto-orcein. There are 51 chromosomes, including 7 small acrocentrics (arrowed).
Two ofthe latter have the characteristics ofthe Philadelphia chromosome (Ph').
FIG. 2.-CAsE 2-Karyotype of cell from 19-hour splenic culture. 2n = 54, plus a fragment
(F). This cell is designated as (h) in Table V. Chromosomal anomalies include a large
acrocentric marker (M); 5 extra chromosomes in the group 6-12, X; trisomies in groups
13-15 and 19, 20, and a monosomy in the group 17, 18. Two Philadelphia chromosomes
(Ph') are present.BRmSH JOURNAL OF CANCER.
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TABLE II.-Case 2-Chromosome Count Distribution in Short-term Culture
ofSpleen Cells
Chromosome No. <42 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 >59
No. of cells 0 2 2 2 2 11 2 0 2 1 3 2 5 13 7 8 30 4 1 0 Total
97
presence of at least 3 cell lines, with 46, 54, and 57 chromosomes: there may be
other lines with 53, 55 and 56 chromosomes. In 57 of these cells, the morpholo-
gical appearances of the small acrocentric chromosomes were near-optimal and
the Ph' status could be reliably assessed. The results are shown in Table IV;
TABLE IV.-Case 2-Phl Status of Cultured Spleen Cells
No. of Ph' chromosomes. . 2 . 1 . 0
No. of cells . . . . 42 . 15 . 0 . . Total 57
no Ph'-negative cells were seen and the majority of cells possessed 2 Ph' chro-
mosomes. Comparison of Ph' status with the chromosome number in each
metaphase showed that all ofthe 15 cells with a single Ph' had 46 chromosomes or
less. Ofthe 42 cells with 2 Ph' chromosomes, 1 had a chromosome number of 47
and the remainder all possessed 49 or more chromosomes. It thus appeared that
gain of an additional Ph' chromosome was closely related to gain of other chro-
mosomes, as the former anomaly only once occurred as an isolated change. The
order in which the various changes occurred is not apparent from these figures;
if gain of an extra Ph' chromosome was the initial step, this line must have been
outgrown by its descendants, as it has only 1 representative among the 57 cells
which could be fully assessed, and only 2 out of the 97 metaphases which were
counted possessed 47 chromosomes.
Karyotypes were constructed from 15 metaphases. The complex karyotypic
changes present are summarized in Table V. The most frequent specific chro-
mosomal aberration, other than gain of a second Ph', was the loss of 1 member of
the group 17, 18. Gain of 2 chromosomes in the group 13-15 occurred in all but
4 of the hyperdiploid cells and 3 of these 4 cells possessed 1 extra group 13-15
chromosome and a large acrocentric marker chromosome (Fig. 2). From this
observation it seems probable that the marker chromosome was derived from a
group 13-15 chromosome, by translocation of material onto the long arms. All
of the hyperdiploid cells possessed additional group 6-12, X chromosomes: the
number of these extra chromosomes varied from 1 to 8.
DISCUSSION
In chronic granulocytic leukaemia in the chronic phase of the disease, all the
dividing cells seen in direct preparations of bone marrow carry the Philadelphia
chromosome but are otherwise of normal karyotype (Tough et al., 1963). It is
therefore reasonable to assume that the varied cell lines found in Case 1 were
originally derived from a diploid, Ph'-positive ancestral strain. In the sample
examined, this cell type, designated line (b), had only 1 representative. The
majority ofthe marrow cells were removed by one or more cytogenetic steps from
this archetype. The variant karyotypes observed (Table II) are numerous but
possess a pattern from which their possible interrelationships may be deduced.
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TABLE, V.-Case 2-Observed Karyotypic Anomalies
Cell line
a b c d e f g h i j k I
Chromosome No. 57 57 57 56 56 55 55 54 54 51 49 46 Total
No. cells 1 1 1 2 1 1 1 1 1 1 1 3 15
Cytogenetic change
iPh'l ..+ 3
2Phl ±+ ++ ++ + + + ++ .12
+l1(21,22,Y)* + + + + +....+ + ++ .10
+2(21,22,Y)* .+.1
+1(19,20).+ . + + ++ ++±.. .10
+2(19,20) . .+. 1
-1(17,18). .+ + ++ + +.11
+2(13-15). ± + + . . . .8
+1(13-15),+Marker .+ ..± ...+ .3
+8(6-12,X) I .
±7(6--12,X) + . + . +.. 6
+5(6-12,X) + + . .2
±4(6-12,X) .+±.2
+1(6-12,X) I ..
+1(3). ±+. 2
1(Fragment) .++ + . ++ . ± .8
+2 (Fragment) ..+.1
* The Ph' chromosome is considered as a member of the group 21, 22, Y and most cells with an
extra Ph' show a gain of 1 chromosome in this group.
The cell lineage which best explains these observations isrepresented schematically
in Fig. 3.
The loss of a medium range chromosome from the original line would produce
the cells of category (a). This loss may well have been random and due to the
technique of preparation. Thus there is insufficient evidence for regarding the 2
cells in group (a) as a true line and they will not be considered further.
If a cell of line (b) gains an extra Philadelphia chromosome, line (d) results.
Further gain of a morphologically normal small acrocentric chromosome would
produce line (h), which by addition of a group 17, 18 chromosome can become line
(i). The step from line (i) to line (j) involves the acquisition of 2 extra group 6-12,
X chromosomes: this might be a two-step procedure, although no intermediate
form with 50 chromosomes was seen. The number ofcells in each ofthe categories
(d), (h), (i) and (j) is small but their possible interrelationship would seem to justify
our regarding them as a series oftrue cell lines. The most obvious mechanism for
the series of chromosome gains necessary to convert cells ofline (b) to cells ofline
(j) is nondisjunction. The failure to demonstrate cells with the reciprocal change
which have lost the same chromosome is not a conclusive objection to this inter-
pretation. Presumably such hypodiploid cells will commonly be nonviable. It is
probable that cells of abnormal karyotype are especially prone to nondisjunction
(Court Brown, 1962; Ford and Clarke, 1963), and that both the prevalence and the
variety ofkaryotypically aberrant cells increase asthe disease progresses (Pedersen,
1966, 1967a). It must be uncertain whether the observed cell lines are the result
of randomly occurring nondisjunction followed by the effects of selection on a
cytogenetically diverse population, or the product of a series of controlled karyo-
typic changes. Another possibility, which at present appears less likely, is thatCYTOGENETIC EVOLUTION OF LEUKAEMIA
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FiG. 3.-Scheme for possible interrelationships of the cell lines described in Table II. The
figures in parentheses beneath each initial letter are the chromosome numbers of each line.
The stem-line (b) has 1 Phl chromosome.
aberrant cell lines with additional chromosomes arise as a result ofendoreduplica-
tion of individual chromosomes. Endoreduplication resulting in pDlyploid
chromosome numbers in neoplastic cells, including human leukaemic cells, is well
established but the evidence for endoreduplication of individual chromosomes is
fragmentary. Houston, Levin and Ritzmann (1964) have described this pheno-
menon in an untreated adult with acute leukaemia, and their report is convin-
cingly illustrated. The same phenomenon has also been briefly reported by
Lejeune (1964), although in this case the source ofthe material is not clear.
It appears thatthe other cell types present, (c), (e), (f) and (g), must have arisen
from line (b) by a separate cytogenetic evolutionary pathway. The first step,
gain of a medium-sized chromosome, would produce line (c). Nondisjunction of
the Philadelphia chromosome at a subsequent mitosis would then produce line
(g), with 6 small acrocentric chromosomes, including two Ph' chromosomes.
Both (c) and (g) are undoubted cell lines, with 4 and 7 representatives respec-
tively. Line (e), which has only one representative, might be dismissed as a
broken cell, e.g. a member of line (g) which has lost a small acrocentric chromo-
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some. However, a cell of the same karyotype as line (e) (i.e. with 2 Ph1 chromo-
somes but possessing only 5 small acrocentric chromosomes), is the only obvious
ancestor for the cells of line (f). Accordingly we postulate that in a cell of group
(c) a further deletion occurs in a No. 21 chromosome to produceline (e), with 2
Philadelphia chromosomes. Gain of a group 6-12, X chromosome then produces
cells of line (f). The hypothesis that the deletion which originally produced the
Philadelphia chromosome of line (b) can be repeated at a late stage of the disease
is obviously contentious. However, the alternative-production of (e) by a pro-
cess of devolution, with loss of a normal small acrocentric chromosome, from
line (g)-also seems unlikely. The only other method by which a cell can acquire
2 Philadelphia chromosomes without an increase in ploidy is a double nondisjunc-
tion in which both the chromatids of the Ph' pass to one daughter cell and both
chromatids of the remaining normal 21 chromosome go to the other daughter
cell. This is an improbable event, and more important, the 2 Philadelphia
chromosomes in the cells of both line (e) and line (f) were non-identical and hence
should not be derived from sister chromatids.
There are obviously many alternative schemes to account for the cell population
we observed, but the above hypothesis appears to explain the facts most economi-
cally. A number of alternative models have been rejected on the grounds of their
gross complexity and consequent improbability. That the cytogenetic picture
may have arisen in apurely chaotic fashion also seems unacceptable in view of the
strong suggestion ofpattern present in the cell population.
Several of the cell lines found in Case1 have not been previously described.
Cells karyotypically identical with line (d) of Case1 have been reported in 3
other cases of chronic granulocytic leukaemia in acute transformation (Ham-
mouda, 1963; Hammouda, Quaglino andHayhoe, 1964 (Case 4); Spiers and Baikie,
1965; Kiossoglou, Mitus andDameshek, 1965 (Case 1)). The second case of Ham-
mouda and co-workers (1964) had a cell line with 53 chromosomes, which resembled
line (j) of our Case1 but had gained a group 13-15 chromosome and a second
additionalgroup 17, 18 chromosome. The acqulsition ofextra chromosomes ofthe
group 6-12, X, which occurred in several cell lines in both Case1 and Case 2, has
frequently been observed in chronic granulocytic leukaemia (Hammouda et al.,
1964; Pedersen, 1964; Ruffie et al., 1965; Erkman, Crookston and Conen, 1966)
and is not always associated with acute transformation. The occurrence of
hypodiploid cell lines appears to have been reported in only one case of acute
transformation (Kiossoglou et al., 1965 (Case 2)) and was not convincingly demon-
strated in either of our cases.
The range ofkaryotypes observed in Case 2 (Table V) is so great that random
cytogenetic change might be postulated as the probable explanation. However,
certain karyotypic changes are seen to occur in many cells-for example, the
acquisition ofsecondPh'chromosomes and the numerical anomalies in the groups
17, 18 and 13-15 already referred to. It is also apparent that cell (c), the 2 cells
designated (d), and cell (e) are closely related, while the cells (a), (b), and (g) are
only onestep further removed. The cells (f) and (h) appear related to one another.
The 3 cellsdesignated (1) appear to be the original leukaemic stem-line, since their
only anomaly is the possession of the Ph' chromosome.
From a consideration of the data contained in Table V, the following hypo-
thesis may be evolved as to the process ofkaryotypic evolution from the parent
line, (1).
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(i) The acquisition of a second Ph' is an early change and usually results in
the gain of 1 group 21, 22, Y chromosome, making a total of 6. Cell
(g) appears to have lost one normal chromosome of this group, whereas
cell (f) has gained a Ph' and a normal chromosome, thus possessing 7
small acrocentrics.
(ii) Gain of 1 group 19, 20 chromosome may have occurred next. Cell (b)
gained 2 such chromosomes.
(iii) At this point, the line represented by cell (i) split off and pursued a
separate evolutionary path, acquiring extra No. 1 and No. 3 chromosomes
and extra medium range chromosomes, without participating in any of
the further karyotypic rearrangements common to the other cells.
(iv) Loss of a group 17, 18 chromosome may have been the next cytogenetic
step.
(v) Probably all cells, except (i), next acquired 2 additional group 13-15
chromosomes. In cells (f), (h) and (k) one of these additional large
acrocentric chromosomes appears to have undergone conversion to the
marker chromosome. Thus these cells may have arisen from a common
ancestor in which the latter change took place.
(vi) Gain of a variable number of extra chromosomes in the group 6-12, X
occurred in all cells, including (i), although this latter line had apparently
followed an independent pattern of development in other respects. The
acquisition of extra medium range chromosomes might have occurred:
(a) in a quantitatively variable fashion, before the development of
divergent lines such as (i) and (f), (h) and (k); or (b) after these events,
as a relatively nonspecific process affecting all the neoplastic cells; or (c)
at several stages during the evolution of the observed cell lines.
(vii) The same considerations might apply to the acquisition of 1 or 2 chro-
mosome fragments by most of the cells. From the detailed analysis of
15 karyotypes, no firm decision could be made as to the stage ofneoplastic
cellular evolution at which these fragments were acquired. During the
counting of chromosomes in 97 metaphases, over half the cells were seen
to possess 1 or more small fragments. The distribution by chromosome
count of the cells possessing fragments is shown in Table VI. It is seen
that whereas gain of 1 fragment is common, gain of 2 fragments is un-
common and the acquisition of more than 2 fragments is rare. Fifty-
four cells have acquired 1 or more fragments, and 53 ofthese cells possess
TABLE VI.-Case 2-Occurrence of Chromosomal Fragments Related to
Chromosome Number
No. of cells
No. of Chromosome No.*
fragments <46 46 47 48 49 50 51 52 53 54 55 56 57 58 59 Total
0 . 8 10 2 - 1 - 1 1 2 5 3 2 7 - 1 .43
1 . - 1 - - 1 1 2 1 2 7 3 4 18 3 -.43
2 .1 -1 2 4 1-. 9
3 ..1--. 1
5 ..1.. 1
Total cells. 8 11 2 0 2 1 3 2 5 13 7 8 30 4 1 .97
* Chromosome numbers do not include the fragments.
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more than 48 chromosomes. On the other hand, about one-third of the
76 cells with more than 48 chromosomes do not possess any chromosomal
fragments. These results suggest that the acquisition of fragments
occurs after the cell has attained a hyperdiploid state by the gain of
group 6-12, X chromosomes. It is apparent that the acquisition of
fragments is not a necessary sequel of the hyperdiploid state in these
leukaemic cells. Similarly, the occurrence of fragments is not an en-
tirely random phenomenon, nor is it likely to be an effect of drug treat-
ment, as in either event it is improbable that 20 of the 21 cells with less
than 48 chromosomes should be unaffected.
Three types of abnormal marker chromosome were observed in the 97 meta-
phases examined: the abnormal acrocentric marker previously referred to (Table
V and Fig. 2), a very large submetacentric chromosome, and a large chromosome
which appeared to be dicentric. The occurrence of these markers is shown in
Table VII. No cell possessed more than 1 marker, and 84 cells had no marker.
TABLE VJI.-Case 2-Occurrence of Marker Chromosomes in 97 Metaphases
No. of
Marker cells Chromosome numbers
Large acrocentric . . 6 . 49, 54, 55, 56, 57, 57
Large submetacentric . . 5 . 46, 54, 54, 57, 57
Large dicentric . . . 2 . 42, 50
The relatively low incidence of the abnormal chromosomes in the cell population
may mean thatthese aberrations are arelativelylate development, or alternatively
that their possession confers no survival advantage on the cell in its competition
with cells of other lines. Although marker chromosomes are probably epipheno-
mena in most tumours and consequently lack aetiological significance, they are of
particular interest because they sometimes furnish a guide to theinterrelationships
ofvarious cell lines. As was stated previously, the marker chromosome present in
cells (f), (h) and (k), is probably derived from agroup 13-15 chromosome (Table V).
The cells possessing this large acrocentric marker are probably derived from a
common ancestor, and apart from the marker, display a strong karyotypic
affinity with lines (c), (d) and (e). It is ofinterest that cells (j) and (k) both show
an unusual cytogenetic lesion, monosomy-16, yet areunlikely to possess a common
ancestor, since only (k) carries the marker chromosome, while cells (f) and (h) do
not show monosomy-16. It is possible that one of the karyotypic alterations
which both cells already possessed in common-e.g. monosomy in the group
17, 18-predisposed to the development of monosomy-16 in each cell indepen-
dently.
Ruffie (1963) has suggested that the chromosomal changes occurring in the
cells of acute leukaemia may be divided into two stages. The initial changes
affect the small acrocentric chromosomes (breakage, loss or trisomy) and in the
second stage the chromosome count rises due to gain of chromosomes in other
groups, including the group 6-12, X, and the disease then becomes clinically
overt. This view is a speculative one but receives some support from the evidence
of Reisman, Zuelzer and Thompson (1964) of the importance of persisting
aneuploid stem lines in acute leukaemia. It is interesting to compare this hypo-
thesis with the present findings. Chronic granulocytic leukaemia may be likened
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to acute leukaemia with a prolonged pre-neoplastic stage, in which the cells are
Ph'-positive without other anomaly and the clinical process is not acute. The
genetic material lost from the Philadelphia chromosome appears to regulate
granulopoiesis, and its loss is followed by a profound disorder of this process,
which is nevertheless temporarily reversible by treatment. Additional chro-
mosomal abnormalities commonly appear at or before the time of acute leukaemic
transformation (Baikie, 1964). Thus the phenomenon ofacute leukaemic activity
may be dependent upon a second stage of cytogenetic change. As observed in
our cases, this stage was characterized by an increase in the numbers of Ph'
chromosomes and chromosomes of the group 6-12, X. Thus most of the cells
observed were hyperdiploid and doubly Ph'-positive. In Case 1, gain of addi-
tional normal chromosomes in the group 21, 22, Y and of extra members in the
group 17, 18 was prominent, whereas in Case 2, the only additional members of
group 21, 22, Y were usually Ph' chromosomes, and loss of a chromosome from
group 17, 18 was a regular occurrence.
Recently, de Grouchy and his colleagues (1966) have postulated three models of
clonal evolution which may be followed by the neoplastic cells in chronic granulo-
cytic leukaemia. In the first, evolution proceeds by acquisition and occasionally
duplication of supernumerary chromosomes. In the second model, the main
feature is the loss of specific chromosomes, particularly affecting the group 17, 18.
The third model is characterized by the occurrence of structural rearrangements.
These three processes may occur simultaneously, with a single clone showing
chromosome gains and losses together with structural rearrangements. Case 1
of this report conforms to the first of these models, the cell lines showing a series
of chromosome gains. Acquisition of an extra group 17, 18 chromosome occurred
in several cells; this was a rare event in the cases described by de Grouchy et al.
The karyotypes observed in Case 2 must represent the operation of all three
postulated processes, with gain of a Ph' chromosome and additional members in
the groups 6-12, X, 13-15, and 19, 20; losses from the group 17, 18 and a structural
rearrangement, probably involving a group 13-15 chromosome, to form a large
acrocentric marker. Although none were identical, the karyotypes observed in
our Case 2 have several features in common with those reported in Case 7 of de
Grouchy et al.
The presence of additional Ph' chromosomes in the leukaemic cells has been
reported in at least 20 other cases of chronic granulocytic leukaemia at the stage
of acute transformation. Single cases showing this anomaly have been described
by Kemp, Stafford and Tanner (1964), Hampel (1964), de Grouchy et al. (1965),
Schroeder and Bock (1965), Engel and McKee (1966), Stich et al. (1966), Fitz-
gerald (1966), Rigo, Stannard and Cowling (1966), Widmaier (1966) and Dieska
et al. (1967). Kiossoglou et al. (1965), Erkman et al. (1966) and Duval et al.
(1967) each described 2 cases, and Hammouda et al. (1964) reported 3 cases. We
have observed this anomaly in cultured spleen cells from a female case of acute
transformation reported elsewhere (Spiers and Baikie, 1965). The complement of
autosomes in this case was the same as in line (d) ofCase 1 in the present report.
The occurrence of double Ph' chromosomes in cases of chronic granulocytic
leukaemia before acute transformation is quite rare; Dougan and Woodliff (1965)
and Engel and McKee (1966) have each described 1 case. In the former case, 2
morphologically normal No. 21 chromosomes were also present in each cell, i.e.
the same karyotype as line (h) of our Case 1. More recently, Duvall et at. (1967)
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have described 1 case with double Ph' chromosomes which did not show overt
acute transformation, although peripheral lymphadenopathy was prominent.
Numerical abnormalities of small acrocentric chromosomes other than the
Ph' occurred in some cells from each of our cases. A variety of anomalies of the
chromosome group 21, 22, Y have been reported in the acute transformation of
chronic granulocytic leukaemia. Ruffie and coworkers (1965) have described
loss of a normal No. 21 in this situation and also in de novo acute granulocytic
leukaemia (Ruffie and Lejeune, 1962). In the case reported by Ford and Clarke
(1963), monosomy-21 and loss of the Y chromosome occurred. Loss of a normal
No. 21 sometimes associated with the acquisition of a second Ph', was described
by Fitzgerald (1966). Gain of an additional morphologically normal No. 21
chromosome was found in 2 of the cases of acute transformation reported by
Hammouda et al. (1964) and in 1 of the cases reported by Duvall et al. (1967).
However, in the majority of cases described as having two Ph' chromosomes, the
second Ph' has been an extra chromosome and 1 normal No. 21 chromosome has
been retained.
Many of the karyotypes from Case 2 showed either 2 extra members of the
group 13-15, or 1 extra member in this group plus a large acrocentric marker
chromosome (Fig. 2). Goh (1967) has reported a similar acrocentric marker in
occasional cells from each of 8 cases of acute transformation of chronic granulo-
cytic leukaemia. In some instances the presence of the marker was associated
with numerical abnormalities of the group 13-15 chromosomes. Case 7 of de
Grouchy et al. (1966) showed in all cells a translocation between a group 13-15
chromosome and a No. 2 chromosome. Thus the process of acute transformation
may be associated with a special liability to the occurrence ofstructural rearrange-
ments of the large acrocentric chromosomes.
Anomalies of the chromosome group 17, 18 have been described in at least
6 cases of acute transformation of chronic granulocytic leukaemia. Two cases
described by Pedersen (1964) showed loss of one chromosome from this group,
and a case described by Stich et al. (1966) possessed a probable isochromosome
for chromosome No. 17. Three of the cases described by de Grouchy et al. (1966)
showed loss of one or two members of group 17, 18. We have previously drawn
attention to a possible special role of the chromosomes of group 17, 18 and group
21, 22 in the evolution of reticuloendothelial neoplasms (Spiers and Baikie, 1966).
It is of interest that in both of the present cases of chronic granulocytic leukaemia,
the occurrence of acute transformation was associated with the development of
numerical abnormalities in these chromosome groups.
Case 1 and Case 2 both possessed cell lines with additional chromosomes in the
group 6-12, X. This aberration has been described in some other cases of chronic
granulocytic leukaemia, both in the chronic phase of the disease (Goh, Swisher
and Troup, 1964) and after the occurrence of acute transformation (Levan, Nichols
and Norden, 1963; Pedersen, 1964; de Grouchy et al., 1966; Duvall et al. 1967).
The cytogenetic findings in our 2 cases, and previously reported results, show
that in chronic granulocytic leukaemia at the stage of acute transformation, the
emergent karyotypes may possess a range and variety resembling that found in
acute leukaemia arising de novo. In both of our cases there was a tendency to
accumulate extra autosomes, particularly of the groups 6-12 and 21, 22. This
tendency clearly extends to the partially deleted members of the group 21, 22
termed Philadelphia chromosomes, which may in fact display a very special
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liability to mitotic nondisjunction (Pedersen, 1967b). The new cell lines differ
from those observed in acute leukaemia principally in their possession of the Ph1.
The karyotypic changes occurring during acute transformation are very com-
plex, and the observed cytogenetic picture may at first suggest the occurrence of
random nondisjunctional change. However, closer analysis may reveal an
underlying pattern ofstepwise karyotypic alteration with clonal proliferation and
probable selection effects to produce a population ofclosely related cell lines which
have arisen in a non-random fashion. We suggest that this type of detailed
analysis is a most profitable line ofresearch, as the study of a sufficient number of
cases may reveal some of the basic cytogenetic requirements of tumour cell
evolution.
It has previously been pointed out (Baikie, 1966) that chronic granulocytic
leukaemia offers a particularly good opportunity for the comparison ofcytogenetic
and clinical observations. In its chronic phase, this disease has relatively con-
stant clinical features, associated with a single highly specific cytogenetic anomaly,
the Ph1 chromosome. In the phase of acute transformation, both the clinical
course and the cytogenetic findings are very variable, and the possibility arises of
establishing correlations between the course of the disease and these secondary
chromosomal aberrations, if adequate numbers of patients are studied in detail.
There is an obvious need for such investigations in this unique neoplasm.
SUMMARY
Cytogenetic studies were performed in two cases of chronic granulocytic
leukaemia which hadundergone acute transformation. Chromosome preparations
were made in the first case by a direct technique from bone marrow aspirate,
and in the second case by a newly developed method of splenic cell culture. In
each case, leukaemic cell lines possessing the Philadelphia chromosome (Ph1)
together with additional karyotypic anomalies were demonstrable. In both
cases many cells acquired a second Ph' and hyperdiploid cell lines arose by that
means and by the acquisition of further additional chromosomes. From a de-
tailed analysis of the complex karyotypic alterations present, the stepwise occur-
rence of successive cytogenetic changes could be deduced, and there was evidence
of clonal proliferation of these new cell lines. Information relating to the cyto-
genetic evolution ofindividual neoplasms may be ofgeneral significance in studies
of the natural history of cancer. It is suggested that chronic granulocytic
leukaemia provides a particularly good opportunity for the correlation of cyto-
genetic changes with the progression of a neoplastic process.
This work was supported by a grant from the Anti-Cancer Council ofVictoria.
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